Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim Eisen

Showing results (1-10 of 116) with videos related to

Pageof 12
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2002
Thalidomide in solid malignanciesTim Eisen
BJU International|November 15, 2008
The National Institute of Health and Clinical Excellence rejects new treatments for renal cell cancer: Cinderella's invitation is cancelledTim Eisen
Discovery Medicine|October 17, 2009
Does immunotherapy still have a role in treating kidney cancer?Tim Eisen
European Journal of Cancer (Oxford, England : 1990)|May 25, 2005
Renewed hope for patients with advanced renal cell cancer: Cinderella comes of ageTim Eisen
European Journal of Cancer (Oxford, England : 1990)|November 29, 2015
Tyrosine kinase inhibitors in renal cell cancer: Losing an empire and yet to find a roleTim Eisen
Expert Opinion on Investigational Drugs|December 7, 2021
Combination therapies in clinical trials for renal cell carcinoma: how could they impact future treatments?Will Ince, Tim Eisen
Nature Reviews. Clinical Oncology|June 24, 2009
Immunotherapeutic strategies in kidney cancer--when TKIs are not enoughSwethajit Biswas, Tim Eisen
Targeted Oncology|August 7, 2010
Perspectives in drug development for metastatic renal cell cancerBristi Basu, Tim Eisen
British Journal of Cancer|August 5, 2016
Medical treatment of renal cancer: new horizonsBasma Greef, Tim Eisen
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2004
Kinase inhibition with BAY 43-9006 in renal cell carcinomaTanya Ahmad, Tim Eisen
Pageof 12

Showing results (1-10 of 116) with videos related to

Sort By:
Pageof 12
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2002
Thalidomide in solid malignanciesTim Eisen
BJU International|November 15, 2008
The National Institute of Health and Clinical Excellence rejects new treatments for renal cell cancer: Cinderella's invitation is cancelledTim Eisen
Discovery Medicine|October 17, 2009
Does immunotherapy still have a role in treating kidney cancer?Tim Eisen
European Journal of Cancer (Oxford, England : 1990)|May 25, 2005
Renewed hope for patients with advanced renal cell cancer: Cinderella comes of ageTim Eisen
European Journal of Cancer (Oxford, England : 1990)|November 29, 2015
Tyrosine kinase inhibitors in renal cell cancer: Losing an empire and yet to find a roleTim Eisen
Expert Opinion on Investigational Drugs|December 7, 2021
Combination therapies in clinical trials for renal cell carcinoma: how could they impact future treatments?Will Ince, Tim Eisen
Nature Reviews. Clinical Oncology|June 24, 2009
Immunotherapeutic strategies in kidney cancer--when TKIs are not enoughSwethajit Biswas, Tim Eisen
Targeted Oncology|August 7, 2010
Perspectives in drug development for metastatic renal cell cancerBristi Basu, Tim Eisen
British Journal of Cancer|August 5, 2016
Medical treatment of renal cancer: new horizonsBasma Greef, Tim Eisen
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2004
Kinase inhibition with BAY 43-9006 in renal cell carcinomaTanya Ahmad, Tim Eisen
Pageof 12